Market News
Nov. 15, 2022 TSE Designation of Securities Under Supervision (Confirmation): Nichi-Iko Pharmaceutical Co.,Ltd.
TSE has designated an issue as Securities Under Supervision (Confirmation) as follows.
| １．Issue Name | Nichi-Iko Pharmaceutical Co.,Ltd. stock (Code: 4541, Market Segment: Prime Market) |
| ２．Period of Designation as Securities Under Supervision (Confirmation) | From Nov. 14, 2022 (Mon.) to the day when TSE determines whether the company has fallen under the delisting criteria |
| Provision | Enforcement Rules for Securities Listing Regulations, Rule 604, Paragraph 1, Item (24) (due to falling under a case where the board of directors has made a resolution on a reverse stock split with a split ratio at which the number of all the shares owned by shareholders other than a specified party will be less than one share) |
| ３．Reason | On Nov. 14, 2022, Nichi-Iko Pharmaceutical Co.,Ltd. (hereinafter "the Company") has announced that the Board of Directors of the Company has adopted a resolution regarding a reverse stock split with a ratio at which the number of shares held by the shareholders of the Company (excluding Godo Kaisha JSD (unlisted)) will be less than one share, on condition of the issuance of new shares to Godo Kaisha JSD through a third-party allotment (hereinafter "the Issuance of new shares") and plans to adopt a resolution to put forth an agenda item at the upcoming general shareholder meeting regarding said reserve stock split. If the agenda item is approved in a resolution at the general shareholders meeting of the Company and the Issuance of new shares is implemented, the stock of the Company will be delisted. As such, based on this announcement, TSE deems that the stock of the Company is likely to be delisted and designates such stock as Securities Under Supervision (Confirmation). |
Designation History of Securities Under Supervision & Securities to Be Delisted
DISCLAIMER: This translation may be used for reference purposes only. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. This translation is subject to change without notice. Tokyo Stock Exchange, Inc. and/or Japan Exchange Regulation shall individually or jointly accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.
Enquiry
Tokyo Stock Exchange, Inc. Listing Department, Corporate Disclosure Office, Planning & Coordination, Listed Company Services
TEL:+81-3-3666-0141(Switchboard)